All the news Showing 10 of 182 articles from: Hepatitis BGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Bulevirtide for hepatitis D proves effective in real-world studies Liz Highleyman / 25 January 2022 The entry inhibitor bulevirtide (Hepcludex) led to a reduction in hepatitis delta virus (HDV) viral load and improved liver enzyme levels in real-world studies in France and Austria, according to findings presented ... Prioritise harm reduction services to prevent hepatitis C re-infection, Scottish study finds Keith Alcorn / 24 January 2022 Limiting re-infection with hepatitis C in people who use drugs is most likely to be achieved by intensifying provision of sterile injecting equipment for people using needle and syringe programmes and increasing ... Hepatitis B may increase cancer risk in people with HIV Keith Alcorn / 29 December 2021 People with both HIV and hepatitis B have a higher rate of non-liver cancers compared to other people with HIV, a large European study has found. The study investigators, who have published ... Some people remain at risk for liver cancer despite hepatitis C treatment Liz Highleyman / 22 December 2021 Some people with liver cirrhosis remain at risk for developing hepatocellular carcinoma (HCC) even after hepatitis C treatment, according to study results presented at The Liver Meeting. Not achieving a cure was the biggest ... Hepatitis B treatment for all who need it an "achievable public health goal" for Malawi Keith Alcorn / 13 December 2021 Providing hepatitis B treatment for everyone who needs it in Malawi is an achievable public health goal, researchers from the Malawi-Liverpool-Wellcome Trust programme report, following community surveys in Blantyre, Malawi. Hepatitis B treatment ... People with liver cirrhosis have weaker responses to the Pfizer and Moderna SARS-CoV-2 vaccines Keith Alcorn / 16 November 2021 People with cirrhosis of the liver had delayed and suboptimal responses to the Pfizer or Moderna SARS-CoV-2 vaccines compared to healthy adults, an Italian study has found. People with decompensated cirrhosis had significantly ... Testing COVID-19 patients for viral hepatitis does not detect numerous undiagnosed cases Keith Alcorn / 19 September 2021 Screening people admitted to hospital with COVID-19 for hepatitis C or hepatitis B does not lead to detection of a large number of undiagnosed infections and is likely to be of limited ... Japanese study shows benefits of treating hepatitis C early Keith Alcorn / 24 August 2021 Curing hepatitis C in people with mild fibrosis by the age of 50 reduces their risk of death to the same level as the rest of the population, Japanese researchers report in ... Bulevirtide appears safe and effective for hepatitis D Liz Highleyman / 28 June 2021 The entry inhibitor bulevirtide (Hepcludex) suppressed hepatitis delta viral load and improved liver enzyme levels in a phase III clinical trial, according to late-breaking study results presented this week at the 2021 International Liver ... High prevalence of viral hepatitis among healthcare workers in Africa Keith Alcorn / 21 June 2021 Almost 7% of healthcare workers in Africa have hepatitis B and 5% have hepatitis C, according to a systematic review of published studies. Greater efforts to vaccinate against hepatitis B and improve ... ← Prev12345...19Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Transmission and prevention Diagnosis and monitoring Disease course and symptoms Treatment HIV and HBV HCV and HBV Hepatitis delta Living with HBV Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive